Key result
Type II endoleak predicts an ~85% lower rate of aneurysm sac regression following EVAR.
Why the study?
Aortic aneurysm sac remodeling is a complex process, and the factors influencing sac regression following EVAR remain unclear.
What are the predictors of aneurysm sac regression following elective EVAR, and is sac regression associated with improved clinical outcomes?
Cohort (n=232)
What are the predictors of aneurysm sac regression following elective EVAR, and is sac regression associated with improved clinical outcomes?
Effect estimate: HR 0.15 (95% CI 0.08 - 0.31)
p-value: p=< .001
Sac regression after EVAR is associated with improved clinical outcomes, while factors such as COPD, type II endoleak, severe neck angulation, and greater tortuosity index predict failure of sac regression.
Identified predictors of failed sac regression after EVAR should not change practice; leaves open their role in risk stratification for prospective trials.
Abstract Objective The remodeling of the aortic aneurysm sac is a complex biological process, and the factors that influence sac regression following endovascular abdominal aortic aneurysm repair (EVAR) remain unclear. This study aimed to identify predictors of sac regression and assess its association with clinical outcomes in patients who underwent elective EVAR. Methods We retrospectively reviewed a cohort of 232 patients who underwent EVAR and had pre-operative and follow-up CT angiography (CTA). Patients were categorized into sac regression and sac non-regression based on CTA. Univariate and multivariate Cox proportional hazards models were used to identify factors predictive of sac regression. Additionally, we evaluated the association between aneurysm sac regression and clinical outcomes. Results Among the 232 patients included in the study, 124 patients (53.45%) experienced sac regression following EVAR. Univariate analysis revealed that sex, chronic obstructive pulmonary disease (COPD), chronic kidney disease (CKD), glomerular filtration rate (GFR), total cholesterol (TC), endoleak II, use of statins, aortic aneurysm tortuosity index (TI) and severely angulated neck (SAN) of pre-EVAR and post-EVAR were associated with sac regression following EVAR. In multivariate analysis, type II endoleak (hazard ratio [HR], 0.15; 95% CI, 0.08 - 0.31; P < .001), SAN of post-EVAR (HR, 0.52; 95% CI, 0.28 - 0.98; P = .044), COPD (HR, 0.40; 95% CI, 0.23 - 0.71; P = .002) and greater TI (HR, 0.38; 95% CI, 0.23 - 0.60; P < .001) were identified as negative predictors of sac regression. Patients with non-regression of the sac had a significantly higher rate of aneurysm-related mortality (P = .031), re-intervention (P < .001) and delayed rupture (P = .015). Conclusions Our observational study suggests sac regression following EVAR is associated with improved clinical outcomes. The presence of COPD, endoleak II, a SAN of post-EVAR, and greater TI are identified as potential risk factors for sac non-regression.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2025) conducted a cohort in Abdominal aortic aneurysm (n=232). Endovascular abdominal aortic aneurysm repair (EVAR) was evaluated on Sac regression following EVAR (HR 0.15, 95% CI 0.08 - 0.31, p=< .001). Type II endoleak (HR 0.15; 95% CI 0.08-0.31), COPD, severely angulated neck, and greater tortuosity index were significant negative predictors of aneurysm sac regression following EVAR.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: